Furthermore, Engel et al. reported a significant molecular signature in which MSH6 mutation carriers are associated with low frequency of CTNNB1 mutations and high frequency of APC mutations, suggesting that in these patients the onset of MMR deficiency only occurs after adenoma formation. This evidence concerns the gene MSH6 and adenoma.